Related Experiment Video
Updated: Mar 10, 2026

08:01
A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells
Published on: August 29, 2020
2.7K
Harnessing Cellular Feeling: Epigenetic to Mechanical Memory as a Framework for Stem Cell Manufacturing.
Mee-Hae Kim1, Masahiro Kino-Oka1,2
1Department of Biotechnology, Graduate School of Engineering, The University of Osaka, Suita, Osaka, Japan.
Biotechnology and Bioengineering
|March 9, 2026
Summary
We propose a new framework for stem cell therapies, viewing cellular "feeling" and memory dynamics as designable properties. This fluctuation-aware Quality by Design (QbD) approach aims to improve the reliability of living medicines.
Area of Science:
- Regenerative Medicine
- Cellular Biology
- Manufacturing Science
Background:
- Stem cell therapies offer great promise but face manufacturing and clinical variability challenges.
- Current Quality by Design (QbD) frameworks are insufficient for dynamic living cell products.
- Cellular responses to environmental factors introduce complexity in cell product quality.
Purpose of the Study:
- To introduce a novel interpretive lens for understanding cellular variability in manufacturing.
- To propose a new paradigm, fluctuation-aware Quality by Design (QbD), for living medicines.
- To reframe cellular variability not as noise but as a harnessable property.
Main Methods:
- Utilizing "kimochi" (cellular feeling) as a metaphor for cellular environmental sensing and memory inscription.
- Framing cellular variability through measurable memory dynamics and epigenetic plasticity.
- Developing a fluctuation-aware QbD framework with standardized memory metrics, multiscale modeling, and adaptive process control.
Main Results:
- Cellular "feeling" reflects the integration of biochemical and mechanical inputs into cellular memory.
- Ex vivo culture transitions cells from epigenetic plasticity to mechanically stabilized states.
- The proposed QbD framework enables harnessing fluctuation for reproducible and scalable living medicines.
Conclusions:
- A new framework, fluctuation-aware QbD, is proposed for living medicines.
- This approach leverages cellular "feeling" and memory dynamics to manage variability.
- The goal is to achieve reproducible, scalable, and clinically reliable living therapies.
Related Concept Videos
Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Somatic to iPS Cell Reprogramming
2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Maintenance of the ES Cell State
2.8K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K

